GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹7,870 Cr | ₹9,457 Cr | ₹9,211 Cr | ₹7,234 Cr | ₹6,330 Cr |
What is the latest Profit & Loss Account Balance ratio of GLENMARK PHARMACEUTICALS ?
Year | Profit & Loss Account Balance |
---|---|
Mar2024 | ₹7,870 Cr |
Mar2023 | ₹9,457 Cr |
Mar2022 | ₹9,211 Cr |
Mar2021 | ₹7,234 Cr |
Mar2020 | ₹6,330 Cr |
How is Profit & Loss Account Balance of GLENMARK PHARMACEUTICALS Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2024 | ₹7,870 Cr | -16.78 | |
Mar2023 | ₹9,457 Cr | 2.67 | |
Mar2022 | ₹9,211 Cr | 27.33 | |
Mar2021 | ₹7,234 Cr | 14.28 | |
Mar2020 | ₹6,330 Cr | - |
Compare Profit & Loss Account Balance of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹41,680.9 Cr | -7.3% | -4.8% | 72.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹421,527.0 Cr | -3.8% | -3% | 34.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,037.0 Cr | 0.9% | 0.4% | 53.5% | Stock Analytics | |
CIPLA | ₹116,854.0 Cr | -2.8% | -0.1% | 9.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,746.0 Cr | -2.4% | 5.5% | 17.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,093.9 Cr | -2.4% | -0.3% | 42.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -7.3% |
-4.8% |
72.3% |
SENSEX | -1.8% |
-6.6% |
7.1% |
You may also like the below Video Courses